The association of Toll-like receptor 4 gene polymorphisms with the development of emphysema in Japanese subjects: A case control study

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Ito, Michiko ^a   Hanaoka, Masayuki ^a   Droma, Yunden ^a   Kobayashi, Nobumitsu ^a   Yasuo, Masanori ^a   Kitaguchi, Yoshiaki ^a   Horiuchi, Toshimichi ^a   Ikegawa, Kayoko ^a   Katsuyama, Yoshihiko ^b   Kubo, Keishi ^a   Ota, Masao ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SHINSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MUS;

TLR4 PROTEIN, HUMAN; TOLL LIKE RECEPTOR 4;

AGED; ALLELE; ARTICLE; ASIAN; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; EMPHYSEMA; FEMALE; FORCED EXPIRATORY VOLUME; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HAPLOTYPE; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PHENOTYPE; RISK; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION;

AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; EMPHYSEMA; FEMALE; FORCED EXPIRATORY VOLUME; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

EID: 84855894364     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-36     Document Type: Article

References (46)

1. World Health Organization: Chronic obstructive pulmonary disease (COPD). http://www.who.int/respiratory/copd/en/index.html
2. Evidence-based health policy: lessons from the global burden of disease study. Murray CJL, Lopez AD, Science 1996 274 740 743 10.1126/science.274.5288. 740 8966556 (Pubitemid 26398244)
3. Chronic obstructive pulmonary disease: risk factors, pathophysiology and pathogenesis. Snider GL, Annu Rev Med 1989 40 411 429 10.1146/annurev.me.40. 020189.002211 2658758 (Pubitemid 19145366)
4. An animal model of autoimmune emphysema. Taraseviciene-Stewart L, Scerbavicius R, Choe KH, Moore M, Sullivan A, Nicolls MR, Fontenot AP, Tuder RM, Voelkel NF, Am J Respir Crit Care Med 2005 171 734 742 10.1164/rccm.200409- 1275OC 15563631 (Pubitemid 40471144)
5. Genetics and pulmonary medicine. 10: Genetic epidemiology of pulmonary function. Chen Y, Thorax 1999 54 818 824 10.1136/thx.54.9.818 10456975 (Pubitemid 29401545)
6. Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations. Hersh CP, Demeo DL, Lange C, Litonjua AA, Reilly JJ, Kwiatkowski D, Laird N, Sylvia JS, Sparrow D, Speizer FE, Weiss ST, Silverman EK, Am J Respir Cell Mol Biol 2005 33 71 78 10.1165/rcmb.2005-0073OC 15817713 (Pubitemid 40961016)
7. Genetics of COPD. Molfino NA, Chest 2004 125 1929 1940 10.1378/chest.125.5.1929 15136409 (Pubitemid 38648430)
8. The association of transforming growth factor beta 1 gene polymorphisms with the emphysema phenotype of COPD in Japanese. Ito M, Hanaoka M, Droma Y, Hatayama H, Sato E, Katsuyama Y, Fujimoto K, Ota M, Intern Med 2008 47 1387 194 10.2169/internalmedicine.47.1116 18670143
9. ECLIPSE Study NETT Investigators. genome-wide association study identifies BICD1 as a susceptibility gene for emphysema. Kong X, Cho MH, Anderson W, Coxson HO, Muller N, Washko G, Hoffman EA, Bakke P, Gulsvik A, Lomas DA, Silverman EK, Pillai SG, Am J Respir Crit Care Med 2011 183 43 49 10.1164/rccm.201004-0541OC 20709820
10. Toll-like receptors are key participants in innate immune responses. Arancibia SA, Beltrán CJ, Aguirre IM, Silva P, Peralta AL, Malinarich F, Hermoso MA, Biol Res 2007 40 2 97 112 18064347 (Pubitemid 350111016)
11. Toll-like receptors: critical proteins linking innate and acquired immunity. Akira S, Takeda K, Kaisho T, Nat Immunol 2001 2 675 680 10.1038/90609 11477402 (Pubitemid 32747155)
12. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Hajjar AM, Ernst RK, Tsai JH, Wilson CB, Miller SI, Nat Immunol 2002 3 354 359 10.1038/ni777 11912497 (Pubitemid 34308623)
13. Bacterial endotoxin is an active component of cigarette smoke. Hasday JD, Bascom R, Costa JJ, Fitzgerald T, Dubin W, Chest 1999 115 829 835 10.1378/chest.115.3.829 10084499 (Pubitemid 29129968)
14. Toll-like receptor 4 deficiency causes pulmonary emphysema. Zhang X, Shan P, Jiang G, Cohn L, Lee PJ, J Clin Invest 2006 116 3050 3059 10.1172/JCI28139 17053835 (Pubitemid 44684490)
15. Inducible activation of TLR4 confers resistance to hyperoxia-induced pulmonary apoptosis. Qureshi ST, Zhang X, Aberg E, Bousette N, Giaid A, Shan P, Medzhitov RM, Lee PJ, J Immunol 2006 176 4950 4958 16585591
16. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL, Schwartz DA, Nat Genet 2000 25 187 191 10.1038/76048 10835634 (Pubitemid 30394990)
17. Polymorphisms of TLR4: rapid genotyping and reduced response to lipopolysaccharide of TLR4 mutant alleles. Schmitt C, Humeny A, Becker CM, Brune K, Pahl A, Clin Chem 2002 48 1661 1667 12324481
18. Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. Agnese DM, Calvano JE, Hahm SJ, Coyle SM, Corbett SA, Calvano SE, Lowry SF, J Infect Dis 2002 186 1522 1525 10.1086/344893 12404174 (Pubitemid 35286126)
19. Toll-like receptor 4 polymorphisms and atherogenesis. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, Willeit J, Schwartz DA, N Engl J Med 2002 347 185 192 10.1056/NEJMoa012673 12124407 (Pubitemid 34764822)
20. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, Gustot T, Quertinmont E, Abramowicz M, Van Gossum A, Devière J, Rutgeerts P, Gut 2004 53 987 992 10.1136/gut.2003.030205 15194649 (Pubitemid 38824157)
21. The Toll-like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and/or outcome. Radstake TR, Franke B, Hanssen S, Netea MG, Welsing P, Barrera P, Joosten LA, van Riel PL, van den Berg WB, Arthritis Rheum 2004 50 999 1001 10.1002/art.20114 15022344 (Pubitemid 38326201)
22. Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the cancer prostate in Sweden study. Zheng SL, Augustsson-Bälter K, Chang B, Hedelin M, Li L, Adami HO, Bensen J, Li G, Johnasson JE, Turner AR, Adams TS, Meyers DA, Isaacs WB, Xu J, Grönberg H, Cancer Res 2004 64 2918 2922 10.1158/0008-5472.CAN-03-3280 15087412 (Pubitemid 38500633)
23. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer. Chen YC, Giovannucci E, Lazarus R, Kraft P, Ketkar S, Hunter DJ, Cancer Res 2005 65 11771 11778 10.1158/0008-5472.CAN-05-2078 16357190 (Pubitemid 41821739)
24. Association of TLR4-T399I polymorphism with chronic obstructive pulmonary disease in smokers. Speletas M, Merentiti V, Kostikas K, Liadaki K, Minas M, Gourgoulianis K, Germenis AE, Clin Dev Immunol 2009 2009 6 doi:10.1155/2009/ 260286
25. Association of the ASP299GLY TLR4 polymorphism with COPD. Rohde G, Klein W, Arinir U, Hagedorn M, Duerig N, T Bauer T, Gillissen A, Schultze-Werninghaus G, T Epplen J, Respir Med 2006 100 5 892 896 10.1016/j.rmed.2005.08.018 16219455
26. Toll-like receptor (TLR) 4 polymorphisms and COPD. Sabroe I, Whyte MK, Wilson AG, Dower SK, Hubbard R, Hall I, Thorax 2004 59 81 14694258 (Pubitemid 38067980)
27. Toll-like receptors and chronic lung disease. Chaudhuri N, Dower SK, Whyte MK, Sabroe I, Clin Sci Lond 2005 109 125 133 10.1042/CS20050044 16033327 (Pubitemid 41117295)
28. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, Tripp RA, Walsh EE, Freeman MW, Golenbock DT, Anderson LJ, Finberg RW, Nat Immunol 2000 1 398 401 10.1038/80833 11062499
29. Involvement of TLR 2 and TLR 4 in cellular activation by high mobility group box 1 protein (HMGB1). Park JS, Svetkauskaite D, He Q, Kim JY, Strassheim D, Ishizaka A, Abraham E, J Biol Chem 2004 279 7370 7377 14660645 (Pubitemid 38294612)
30. Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. Guillot L, Balloy V, McCormack FX, Golenbock DT, Chignard M, Si-Tahar M, J Immunol 2002 168 5989 5992 12055204 (Pubitemid 34620010)
31. The extra domain A of fibronectin activates Toll-like receptor 4. Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka ST, Rose J, Chow JC, Strauss JF, J Biol Chem 2001 276 10229 10233 10.1074/jbc.M100099200 11150311
32. Fibrinogen stimulates macrophage chemokine secretion through Toll-like receptor 4. Smiley ST, King JA, Hancock WW, J Immunol 2001 167 2887 2894 11509636 (Pubitemid 32768923)
33. Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C, Simon JC, J Exp Med 2002 195 99 111 10.1084/jem.20001858 11781369 (Pubitemid 34074500)
34. Tobacco smoking inhibits expression of proinflammatory cytokines and activation of IL-1R-associated kinase, p38, and NF-kappaB in alveolar macrophages stimulated with TLR2 and TLR4 agonists. Chen H, Cowan MJ, Hasday JD, Vogel SN, Medvedev AE, J Immunol 2007 179 6097 6106 17947684
35. Cells, mediators and Toll-like receptors in COPD. Sarir H, Henricks PA, van Houwelingen AH, Nijkamp FP, Folkerts G, Eur J Pharmacol 2008 585 346 353 10.1016/j.ejphar.2008.03.009 18410916
36. Evidence for association between a Toll-like receptor 4 gene polymorphism and moderate/severe periodontitis in the Japanese population. Fukusaki T, Ohara N, Hara Y, Yoshimura A, Yoshiura K, J Periodont Res 2007 42 541 545 10.1111/j.1600-0765.2007.00979.x 17956467
37. Toll-like receptor 4 +3725 G/C polymorphism, Helicobacter pylori seropositivity, and the risk of gastric atrophy and gastric cancer in Japanese. Hishida A, Matsuo K, Goto Y, Mitsuda Y, Hiraki A, Naito M, Wakai K, Tajima K, Hamajima N, Helicobacter 2009 14 47 53 10.1111/j.1523-5378.2009.00659.x 19191896
38. Association analysis of Toll-like receptor 4 polymorphisms with autoimmune pancreatitis. Umemura T, Katsuyama Y, Hamano H, Kitahara K, Takayama M, Arakura N, Kawa S, Tanaka E, Ota M, Hum Immunol 2009 70 742 746 10.1016/j.humimm.2009.05.009 19500628
39. Lack of association between toll-like receptor 4 gene polymorphisms and sarcoidosis-related uveitis in Japan. Asukata Y, Ota M, Meguro A, Katsuyama Y, Ishihara M, Namba K, Kitaichi N, Morimoto S, Kaburaki T, Ando Y, Takenaka S, Inoko H, Ohno S, Mizuki N, Mol Vis 2009 15 2673 2682 20011079
40. Bias in odds ratios by logistic regression modelling and sample size. Nemes S, Jonasson JM, Genell A, Steineck G, BMC Med Res Methodol 2009 9 56 10.1186/1471-2288-9-56 19635144
41. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2010: Global Strategy for the Diagnosis, Management and Prevention of COPD. http://www.goldcopd.org/
42. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, Weel CV, Zielinski J, Am J Respir Crit Care Med 2007 176 532 555 10.1164/rccm.200703-456SO 17507545 (Pubitemid 47403272)
43. Computed tomography in pulmonary emphysema. Goddard PR, Nicholson EM, Laszlo G, Watt I, Clin Radiol 1982 33 379 387 10.1016/S0009-9260(82)80301-2 7083738 (Pubitemid 12081355)
44. The National Center for Biotechnology Information database. http://www.ncbi.nlm.nih.gov/snp/
45. Haploview: analysis and visualization of LD and haplotype maps. Barrett JC, Fry B, Maller J, Daly MJ, Bioinformatics 2005 21 263 265 10.1093/bioinformatics/bth457 15297300 (Pubitemid 40202029)
46. The structure of haplotypeblocks in the human genome. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D, Science 2002 296 2225 2229 10.1126/science. 1069424 12029063 (Pubitemid 34680308)